Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Clostridium Difficile Partnering Directory 2018

Research and Markets
Posted on: 05 Apr 18
Global Clostridium Difficile Partnering Directory 2018

PR Newswire

DUBLIN, April 5, 2018

DUBLIN, April 5, 2018 /PRNewswire/ --

The "Global Clostridium difficile Partnering 2012 to 2018" report has been added to ResearchAndMarkets.com's offering.


The Global Clostridium difficile Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Key Topics Covered:





Executive Summary



Chapter 1 - Therapy partnering trends in numbers



Partnering in numbers - by year


Partnering in numbers - most active


Partnering in numbers - by industry sector


Partnering in numbers - by deal type


Partnering in numbers - by technology type


Partnering in numbers - by stage of development



Chapter 2 - Most active dealmakers



Chapter 3 - Partnering deals directory



Partnering deals directory - by company A-Z


Partnering deals directory - by deal value


Partnering deals directory - by industry sector


Partnering deals directory - by deal type


Partnering deals directory - by stage of development


Partnering deals directory - by technology area



Chapter 4 - Partnering deals with a contract document



For more information about this report visit

https://www.researchandmarkets.com/research/5tszvj/global?w=5

Media Contact:




Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



View original content:http://www.prnewswire.com/news-releases/global-clostridium-difficile-partnering-directory-2018-300624942.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 05/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.